Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
Beam Therapeutics | DEFA14A: Others
Beam Therapeutics | DEF 14A: Definitive information statements
Beam Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Beam Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Beam Therapeutics | 8-K: Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
Beam Therapeutics | DEFA14A: Others
Beam Therapeutics | DEF 14A: Definitive proxy statements
Beam Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Beam Therapeutics | 8-K: Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
Beam Therapeutics | 8-K: Current report
No Data